130 related articles for article (PubMed ID: 12952271)
1. Zardaverine and aerosolised iloprost in a model of acute respiratory failure.
Schermuly RT; Leuchte H; Ghofrani HA; Weissmann N; Rose F; Kohstall M; Olschewski H; Schudt C; Grimminger F; Seeger W; Walmrath D
Eur Respir J; 2003 Aug; 22(2):342-7. PubMed ID: 12952271
[TBL] [Abstract][Full Text] [Related]
2. Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension.
Schermuly RT; Ghofrani HA; Enke B; Weissmann N; Grimminger F; Seeger W; Schudt C; Walmrath D
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1500-6. PubMed ID: 10556112
[TBL] [Abstract][Full Text] [Related]
3. Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchange.
Schermuly RT; Roehl A; Weissmann N; Ghofrani HA; Schudt C; Tenor H; Grimminger F; Seeger W; Walmrath D
J Pharmacol Exp Ther; 2000 Feb; 292(2):512-20. PubMed ID: 10640287
[TBL] [Abstract][Full Text] [Related]
4. Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivity.
Schermuly RT; Krupnik E; Tenor H; Schudt C; Weissmann N; Rose F; Grimminger F; Seeger W; Walmrath D; Ghofrani HA
Am J Respir Crit Care Med; 2001 Nov; 164(9):1694-700. PubMed ID: 11719312
[TBL] [Abstract][Full Text] [Related]
5. Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension.
Walmrath D; Schermuly R; Pilch J; Grimminger F; Seeger W
Eur Respir J; 1997 May; 10(5):1084-92. PubMed ID: 9163651
[TBL] [Abstract][Full Text] [Related]
6. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
7. Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors.
Schermuly RT; Inholte C; Ghofrani HA; Gall H; Weissmann N; Weidenbach A; Seeger W; Grimminger F
Respir Res; 2005 Jul; 6(1):76. PubMed ID: 16033645
[TBL] [Abstract][Full Text] [Related]
8. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
[TBL] [Abstract][Full Text] [Related]
9. Prostacyclin and milrinone by aerosolization improve pulmonary hemodynamics in newborn lambs with experimental pulmonary hypertension.
Kumar VH; Swartz DD; Rashid N; Lakshminrusimha S; Ma C; Ryan RM; Morin FC
J Appl Physiol (1985); 2010 Sep; 109(3):677-84. PubMed ID: 20616229
[TBL] [Abstract][Full Text] [Related]
10. Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs.
Schermuly RT; Pullamsetti SS; Breitenbach SC; Weissmann N; Ghofrani HA; Grimminger F; Nilius SM; Schrör K; Kirchrath JM; Seeger W; Rose F
Respir Res; 2007 Jan; 8(1):4. PubMed ID: 17257398
[TBL] [Abstract][Full Text] [Related]
11. Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment.
Petkov V; Ziesche R; Mosgoeller W; Schenk P; Vonbank K; Stiebellehner L; Raderer M; Brunner C; Kneussl M; Block LH
Thorax; 2001 Sep; 56(9):734-6. PubMed ID: 11514696
[TBL] [Abstract][Full Text] [Related]
12. Comparison of pharmacokinetics and vasodilatory effect of nebulized and infused iloprost in experimental pulmonary hypertension: rapid tolerance development.
Schermuly RT; Schulz A; Ghofrani HA; Breitenbach CS; Weissmann N; Hildebrand M; Kurz J; Grimminger F; Seeger W
J Aerosol Med; 2006; 19(3):353-63. PubMed ID: 17034310
[TBL] [Abstract][Full Text] [Related]
13. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
Olschewski H; Walmrath D; Schermuly R; Ghofrani A; Grimminger F; Seeger W
Ann Intern Med; 1996 May; 124(9):820-4. PubMed ID: 8610951
[TBL] [Abstract][Full Text] [Related]
14. Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome.
Zwissler B; Kemming G; Habler O; Kleen M; Merkel M; Haller M; Briegel J; Welte M; Peter K
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1671-7. PubMed ID: 8970353
[TBL] [Abstract][Full Text] [Related]
15. Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension.
Schermuly RT; Roehl A; Weissmann N; Ghofrani HA; Leuchte H; Grimminger F; Seeger W; Walmrath D
Am J Physiol Lung Cell Mol Physiol; 2001 Dec; 281(6):L1361-8. PubMed ID: 11704531
[TBL] [Abstract][Full Text] [Related]
16. Urodilatin, a natriuretic peptide stimulating particulate guanylate cyclase, and the phosphodiesterase 5 inhibitor dipyridamole attenuate experimental pulmonary hypertension: synergism upon coapplication.
Schermuly RT; Weissmann N; Enke B; Ghofrani HA; Forssmann WG; Grimminger F; Seeger W; Walmrath D
Am J Respir Cell Mol Biol; 2001 Aug; 25(2):219-25. PubMed ID: 11509332
[TBL] [Abstract][Full Text] [Related]
17. Protection against gas exchange abnormalities by pre-aerosolized PGE1, iloprost and nitroprusside in lung ischemia-reperfusion.
Löckinger A; Schütte H; Walmrath D; Seeger W; Grimminger F
Transplantation; 2001 Jan; 71(2):185-93. PubMed ID: 11213057
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of inhaled prostanoids in experimental pulmonary hypertension.
Kleen M; Habler O; Hofstetter C; Pusch R; Mueller M; Welte M; Zwissler B
Crit Care Med; 1998 Jun; 26(6):1103-9. PubMed ID: 9635662
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment of pulmonary hypertension with aerosolized iloprost.
Machherndl S; Kneussl M; Baumgartner H; Schneider B; Petkov V; Schenk P; Lang IM
Eur Respir J; 2001 Jan; 17(1):8-13. PubMed ID: 11307761
[TBL] [Abstract][Full Text] [Related]
20. Prostacyclin aerosol and inhaled nitric oxide fail to reverse pulmonary vasoconstriction induced by thromboxane analogue in dogs.
Welte M; Zwissler B; Habler O; Kleen M; Messmer K
Acta Physiol Scand; 1995 Jul; 154(3):395-405. PubMed ID: 7572237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
